These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 25455010)

  • 1. Diagnostic evaluation: target organ damage: cardiac.
    Solomon SD
    J Am Soc Hypertens; 2014 Nov; 8(11):848-9; quiz 850. PubMed ID: 25455010
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic evaluation: target organ damage - cardiovascular.
    Kostis JB
    J Am Soc Hypertens; 2014 Nov; 8(11):851-3; quiz 854. PubMed ID: 25455011
    [No Abstract]   [Full Text] [Related]  

  • 3. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
    Verdecchia P; Angeli F; Pittavini L; Gattobigio R; Benemio G; Porcellati C
    Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left-ventricular diastolic dysfunction as a risk factor for dialytic hypotension.
    Rostoker G; Griuncelli M; Loridon C; Benmaadi A; Illouz E
    Cardiology; 2009; 114(2):142-9. PubMed ID: 19521079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of renal resistive index with target organ damage in essential hypertension.
    Doi Y; Iwashima Y; Yoshihara F; Kamide K; Takata H; Fujii T; Kubota Y; Nakamura S; Horio T; Kawano Y
    Am J Hypertens; 2012 Dec; 25(12):1292-8. PubMed ID: 22874890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Practice based evaluation and risk stratification of arterial hypertension. Focus on ECG].
    Martina B
    Praxis (Bern 1994); 2005 Feb; 94(7):245-50. PubMed ID: 15773141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining the blood pressure phenotype in children: when does target organ damage begin?
    Falkner B; DeLoach S
    Hypertension; 2009 Jun; 53(6):905-6. PubMed ID: 19414644
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of left ventricular diastolic function with cardiovascular MRI: what radiologists should know.
    Duarte R; Fernandez-Perez G; Bettencourt N; Sampaio F; Miranda D; França M; Portugal P
    Diagn Interv Radiol; 2012; 18(5):446-53. PubMed ID: 22798156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The problem of the accurate noninvasive diagnosis of left ventricular myocardial hypertrophy in essential hypertension: the role of magnetic resonance tomography].
    Sinitsyn VE; Iurpol'skaia LA; Stukalova OV; Kagan-Ponomarev MIa; Vil'chinskaia MIu; Karpov IuA
    Ter Arkh; 1997; 69(4):13-5. PubMed ID: 9213946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiac complications of hypertension: prospective study at the Principal Hospital in Dakar].
    Wade B; Cloatre G; Thiam M; Gueye PM; Klotz F
    Dakar Med; 1996; Spec No():48-50. PubMed ID: 14520989
    [No Abstract]   [Full Text] [Related]  

  • 11. From hypertension to heart failure: what have we learned?
    Wilson PW
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V1-10. PubMed ID: 10526697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging assessment of left ventricular diastolic function: current and emerging methods.
    Beladan CC; Iliesiu AM; Popescu AC; Coman IM; Ginghina C; Popescu BA
    Acta Cardiol; 2016 Aug; 71(4):379-88. PubMed ID: 27594352
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of mitral valve prolapse to basal left ventricular hypertrophy as determined by cardiac magnetic resonance imaging.
    Zia MI; Valenti V; Cherston C; Criscito M; Uretsky S; Wolff S
    Am J Cardiol; 2012 May; 109(9):1321-5. PubMed ID: 22335854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy.
    Agabiti-Rosei E; Muiesan ML; Salvetti M
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S104-8. PubMed ID: 16565230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-organ damage in treated severe hypertension: close relation to nocturnal blood pressure.
    Fagher B; Valind S; Thulin T
    J Hum Hypertens; 1995 Aug; 9(8):605-10. PubMed ID: 8523373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastolic heart failure.
    Gary R; Davis L
    Heart Lung; 2008; 37(6):405-16. PubMed ID: 18992623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
    Krauser DG; Devereux RB
    Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early repolarization in arrhythmogenic left ventricular cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Nucifora G; Stolfo D; Daleffe E; Piccoli G; Copetti R; Proclemer A
    Int J Cardiol; 2012 Aug; 159(1):66-8. PubMed ID: 22560937
    [No Abstract]   [Full Text] [Related]  

  • 20. Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study.
    Cea-Calvo L; Conthe P; Gómez-Fernández P; de Alvaro F; Fernández-Pérez C;
    Cardiovasc Diabetol; 2006 Nov; 5():23. PubMed ID: 17083718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.